IP Library Granted Patent US 10,815,201
Granted Patent B2
US 10,815,201 · App. 16/851,402 · Granted Oct 27, 2020

Method for producing pitavastatin calcium

Inventors: Naoyuki Watanabe (Fukuoka, JP); Takanobu Iura (Kanagawa, JP); Hideki Oomiya (Fukuoka, JP); Masaki Nagahama (Fukuoka, JP)
Assignee: API CORPORATION
C07D215/14C12P17/12A61K31/47C07B61/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,815,201
App. No.
16/851,402
Granted
Oct 27, 2020
Kind
B2
Abstract

Production of pitavastatin calcium safely on an industrial scale with a high yield and high selectivity at low cost. A method of producing pitavastatin calcium including step (i) for acetalizing a compound represented by the formula (1) to give a compound represented by the formula (3), step (ii) for reacting a compound represented by the formula (3) with an acid to give a compound represented by the formula (4), and step (iii) for hydrolyzing a compound represented by the formula (4) and reacting same with a calcium compound.

Claims (7)

1. A compound represented by the following formula (1′):

wherein R is a straight chain alkyl group having a carbon number of 1-8 or a branched alkyl group having a carbon number of 3-8 and X 1 is methanesulfonic acid.

2. A method for producing a compound represented by the following formula (1):

wherein X is sulfuric acid, hydrochloric acid, methanesulfonic acid, or p-toluenesulfonic acid and R is a straight chain alkyl group having a carbon number of 1-8 or a branched alkyl group having a carbon number of 3-8, comprising

(iv) reacting a compound represented by the following formula (6):

wherein R is as defined above, with sulfuric acid, hydrochloric acid, methanesulfonic acid, or p-toluenesulfonic acid at a reaction temperature of 10-50° C.

3. The production method according to claim 2 , wherein the compound represented by the formula (6) used in (iv) is obtained by bioreaction.

Assignments (3)
CHANGE OF ADDRESS Recorded Aug 21, 2025
From: API CORPORATION
To: API CORPORATION
Reel/Frame 072498/0511 →
MERGER Recorded Aug 21, 2025
From: API CORPORATION
To: UBE CORPORATION
Reel/Frame 072554/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2020
From: WATANABE, NAOYUKI; IURA, TAKANOBU; OOMIYA, HIDEKI; NAGAHAMA, MASAKI
To: API CORPORATION
Reel/Frame 052459/0607 →
Priority Claims (1)
JP 2015-154864 · Aug 5, 2015 · national
Continuity (2)
Division 15749377
Related Publication 20200283390A1 · Sep 10, 2020